Trial Master File - Clinical Systems

Website https://www.demystifiedsolutions.com/trainingDetails/Trial-Master-File-Clinical-Systems-DEMY051458 | Edit Freely

Category

Deadline: June 06, 2017 | Date: June 06, 2017

Venue/Country: Online

Updated: 2017-03-10 16:06:03 (GMT+9)

Call For Papers - CFP

The Code of Federal Regulations states in 21 CFR 312.50: “Sponsors are responsible for… ensuring that the investigation(s) is conducted in accordance with the general investigational plan and protocols contained in the IND.”

The European Directive 2005/28/EC states:“…trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.”

ICH GCP, Section 8.1 describes “essential documents” as those that individually and collectively permit the evaluation of the conduct of a trial and the quality of the data produced.

A consolidated guidance for industry on Good Clinical Practice (GCP) in 1996 was published by the International Conference on Harmonization (ICH). The objective was to provide a unified standard for the United States, European Union, and Japan to facilitate mutual acceptance of clinical data by the regulatory authorities in these global jurisdictions.

The ICH document provided guidance for companies in all ICH regions to establish trial master files that contain key documents that enable the evaluation of the conduct of a trial and the quality of data produced uniformly by all jurisdictions involved. In the US, there is no specific requirement from FDA for companies to prepare a trial master file, but if the regulatory authority requires ICH GCP to be followed, then there is consequently a requirement to create and maintain a trial master file.

Documents contained in the TMF must be available for inspection by the appropriate regulatory authorities at any time during and after the conduct of a clinical trial, and must be submitted to support the request for product approval. This is true for pharmaceuticals, biologics and medical devices.

Why Should You Attend

You should attend this webinar if you are responsible for establishing or maintaining a TMF, or providing quality assurance for data included in the file

Areas Covered in this Webinar

Trial Master File (TMF) background and rationale

The essential documents to include in a TMF

Organizing and maintaining a TMF

Standard Operating Procedure required to support TMF

Inspection of TMF records

Learning Objectives

• Learn what content is required for a TMF for a clinical trial

• Understand how the essential documents demonstrate the conduct of the regulated activities of the investigator and sponsor

• Learn how to establish and maintain a well-organized TMF, and provide quality assurance for the data included

• Understand the importance of developing an effective Standard Operating Procedure (SOP) to support TMF activities

• Learn the importance of developing a consistent system for locating TMF documents, and preparing them for study team use or regulatory inspection

• Learn about best practices and industry standards

Who Will Benefit

• Lead CRAs

• CRA Managers

• Project and/or Study Managers

• Project and/or Clinical Trial Assistants

• Clinical Operations Administrators

• Quality Assurance Personnel

• Sponsor and CRO Personnel involved in Set up, Maintenance, and Auditing of the Trial Master File for Sponsors

• Auditors engaged in the Internal Inspection of Clinical Trial Documentation and Practices

• Consultants working in the Life Sciences Industries responsible for assisting Companies with FDA and EMA Compliance for Labeling Content, Format and Management